Trademark applications and grants for Senju Pharmaceutical Co., Ltd.. Senju Pharmaceutical Co., Ltd. has 15 trademark applications. The latest application filed is for "DELTA"
State Incorporated | JAPAN |
Entity Type | limited company (ltd.) |
Address | 5-8, Hiranomachi 2-chome, Chuo-ku, Osaka OSAKA JAPAN 541-0046 |
Patent Application | Date |
---|---|
THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM 20220296580 - 17/831843 KOIZUMI; Noriko ;   et al. | 2022-09-22 |
EYE DISEASE MARKER 20220221473 - 17/605869 SHIMAZAKI; Jun | 2022-07-14 |
COMPOSITION FOR PREVENTING OR TREATING NEUROTROPHIC KERATITIS WHICH CONTAINS PACAP PEPTIDE OR STABILIZED PACAP PEPTIDE 20220202905 - 17/610844 NAKAJIMA; Takeshi ;   et al. | 2022-06-30 |
RETINAL GANGLION CELL DEATH INHIBITOR 20210346386 - 17/289201 KISHIMOTO; Yayoi ;   et al. | 2021-11-11 |
ANIONIC DRUG-CONTAINING OPHTHALMIC DEVICE 20210268003 - 17/256178 ITO; Yuki ;   et al. | 2021-09-02 |
SEC | 0001728986 | Senju Pharmaceutical Co., Ltd. of JAPAN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.